Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 05, 2025 16:05 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes
November 05, 2025 08:30 ET | Source: Microbot Medical Inc.

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
November 05, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters
November 04, 2025 07:00 ET | Source: Lungpacer Medical USA Inc.

Lungpacer Medical Announces First Enrollments in STARI Trial of Next-Generation Neurostimulation Therapy

Lungpacer Medical today announced the first six patients enrolled in the groundbreaking STARI clinical trial.
November 04, 2025 07:00 ET | Source: EDAP TMS S.A.

EDAP to Present at Jefferies Global Healthcare Conference in London

EDAP to Present at Jefferies Global Healthcare Conference in London Company to Present and Host 1x1 Investor Meetings on Tuesday, November 18th, 2025 AUSTIN, Texas, November 4, 2025 -- EDAP TMS...
November 03, 2025 09:00 ET | Source: Wandercraft

Wandercraft Gains Second FDA Indication Extension for Atalante X in Less Than Two Years, Extending Advanced Robotic Rehabilitation for More Patients with Severe Mobility Loss

Wandercraft earns second FDA clearance for expanded indications of Atalante X, enabling rehab for spinal cord injury and multiple sclerosis patients.
October 31, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers

BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers
October 30, 2025 16:05 ET | Source: BioStem Technologies, Inc.

BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025

BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025
October 30, 2025 08:00 ET | Source: ORGANOX LIMITED

OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation

$1.5 billion OrganOx acquisition by Terumo strengthens global leadership in organ technology and accelerates progress toward making every organ count
October 28, 2025 16:30 ET | Source: SS Innovations

SS Innovations Reports Third Quarter 2025 Financial Results

SS Innovations Reports Third Quarter 2025 Financial Results